Stereotactic Radiotherapy Plus Temozolomide for Refractory Brain Metastases
Condition(s):Brain MetastasesLast Updated:June 6, 2017Completed
Hide Studies Not Open or Pending
Condition(s):Brain MetastasesLast Updated:June 6, 2017Completed
Condition(s):Brain Metastases, AdultLast Updated:April 22, 2022Recruiting
Condition(s):Melanoma; Brain MetastasisLast Updated:July 26, 2018Terminated
Condition(s):Brain MetastasesLast Updated:December 11, 2017Unknown status
Condition(s):Brain MetastasesLast Updated:December 29, 2016Terminated
Condition(s):Brain MetastasesLast Updated:November 26, 2019Completed
Condition(s):Brain MetastasesLast Updated:January 5, 2024Recruiting
Condition(s):Esophageal Neoplasms; Esophagectomy; Brain MetastasesLast Updated:December 4, 2020Unknown status
Condition(s):Brain Metastases; Lung CancerLast Updated:October 24, 2022Terminated
Condition(s):The Optimal Sequence of Radiotherapy and Systematic Tyrosine Kinase Inhibitors in Treating Brain MetastasesLast Updated:April 6, 2021Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.